Results 201 to 210 of about 261,257 (360)

Comorbidities and Healthcare Utilization in 4197 Patients With Prurigo Nodularis in Israel: A Cross‐Sectional Population‐Based Analysis

International Journal of Dermatology, EarlyView.
ABSTRACT Background Prurigo nodularis patients face a significant burden of comorbidities, necessitating a comprehensive approach to care. We aimed to explore the association between prurigo nodularis, its comorbid conditions, and healthcare usage patterns.
Yuliya Valdman‐Grinshpoun, Andrea Zaga, Arnon Dov Cohen, Yochai Schonmann, Tali Czarnowicki   +4 more
wiley   +1 more source

Data-driven cluster analysis and external validation identify phenotypic subgroups in renin-independent aldosteronism with differential cardiovascular risk and therapeutic implications. [PDF]

Front Endocrinol (Lausanne)
Liu Y, Zhang Z, Zhou H, Yan Y, Zhou M, Wang C, Gao M, Tao J, Bao M, Yang T, Sun M, Yang Y.   +11 more
europepmc   +1 more source

Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease

, 2020
Edmund Y. M. Chung, Marinella Ruospo, Patrizia Natale, Davide Bolignano, Sankar D. Navaneethan, Suetonia C. Palmer, Giovanni FM Strippoli   +6 more
openalex   +2 more sources

Total serum T3 and T4 in nontoxic goiter and autonomous adenoma [PDF]

, 1972
Borowzak, H., Habermann, J., Horn, K., Retting, M., Ruhl, T., Scriba, Peter Christian   +5 more
core   +1 more source

Investigation and future trend prediction of disease burden of chronic kidney disease due to diabetes mellitus type 2 globally and in China from 1990 to 2021

Journal of Diabetes Investigation, EarlyView.
This study focuses on the disease burden of chronic kidney disease due to type 2 diabetes (CKD due to type 2 diabetes) globally and in China from 1990 to 2021 and predicts its trend from 2022 to 2031. ABSTRACT Objective To analyze the disease burden of chronic kidney disease due to diabetes mellitus type 2 (CKD due to diabetes mellitus type 2) in China
Jinpeng Du, Ying Tang, Yingcai Qin, Changzhi Meng, Weiqin Cai, Hongqing An   +5 more
wiley   +1 more source

Hormonal response following hemorrhage after severe trauma: an observational prospective study. [PDF]

Crit Care
Werner M, Joulia H, Pussard E, Bergis B, Leblanc PE, Wildenberg L, Huertas A, Vigué B, Duranteau J, Harrois A.   +9 more
europepmc   +1 more source

Linderalactone mitigates diabetic renal injury by inhibiting macrophage inflammation via the Dectin1/Syk/CARD9/IRF5/NF‐κB pathway

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Background Inflammation plays an essential role in the pathogenesis of diabetic nephropathy (DN). Linderalactone (LNL), as a natural sesquiterpene lactone, has been discovered to have anti‐inflammatory activation. However, the effects of linderalactone on diabetes‐associated renal damage remain unclear.
Hao Chen, Sheng Xu, Bingrong Chen, Xishan Xiong, Jinrui Hu, Yuhong Wu, Tianrui Wang, Huishang Wang   +7 more
wiley   +1 more source

Subclinical primary aldosteronism. [PDF]

Arch Endocrinol Metab
Parisien-La Salle S, Brown JM, Tsai CH, Hundemer GL, Vaidya A.   +4 more
europepmc   +1 more source

Renal renin-angiotensin system —What supports and breaks the circle of life—

, 2014
Shoji Kagami
openalex   +2 more sources

The biology of PKM2 in the metabolism and senescence in diabetic kidney disease

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Diabetic kidney disease (DKD) is one of the most common causes of chronic kidney disease that leads to end‐stage kidney disease, and its progression is closely linked to metabolic stress within renal tubular cells. Under long‐term hyperglycemia, cells shift their glucose metabolism from normal oxidative phosphorylation toward glycolysis.
Md. Imrul Kayes, Keizo Kanasaki
wiley   +1 more source